Stability and visual compatibility of daunorubicin and cytarabine during Y-site administration with selected drugs.

Guillaume Sicard,Mélanie Donnette,Bertrand Pourroy,Raphaelle Fanciullino

Stability and visual compatibility of daunorubicin and cytarabine during Y-site administration with selected drugs.

2020

Guillaume Sicard
Mélanie Donnette
Bertrand Pourroy
Raphaelle Fanciullino

e15516Background: Vyxeos is a daunorubicine plus cytarabine liposome indicated in adults patient with newly diagnosed acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) and therap...

Keywords:

Daunorubicin
Cytarabine
Pharmacology
Pathology
Medicine
Oncology
Myeloid leukemia
Internal medicine
CYTARABINE LIPOSOME
newly diagnosed

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations